Hitoshi Kusaba

Suggest Changes
Learn More
OBJECTIVE Oral fluoropyrimidine plus cisplatin is a standard treatment for advanced gastric cancer, but patients with severe peritoneal metastasis often cannot tolerate this regimen. The aim of this(More)